Clinical Trials Logo

Clinical Trial Summary

Validation of biomarkers in a human population for their ability to diagnose the severity of neonatal asphyxia. These biomarkers linked to asphyxia have been identified in animal studies and a preliminary human study.


Clinical Trial Description

The aim of the study is to validate the application of combinations of several laboratory parameters in early postnatal blood samples, for identification of infants, who will suffer from early abnormal neonatal neurological outcome, in a population at risk. The population at risk is defined as term and late preterm (>36 weeks of gestation) human infants following perinatal hypoxia-ischemia with or without postnatal resuscitation, and where the combination of laboratory parameters is derived from a preliminary study performed in Turkey (AAMBI) using a metabolomics approach. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03357250
Study type Observational [Patient Registry]
Source Life Science Inkubator
Contact
Status Completed
Phase
Start date September 2016
Completion date June 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04070560 - Effects of Delayed Cord Clamping During Resuscitation of Newborn Near Term and Term Infants N/A
Completed NCT02572427 - Resident Training Enhanced by New Innovations: Teleintubation N/A
Completed NCT03354208 - Asphyxia Associated Metabolite Biomarker Investigation (AAMBI)
Completed NCT00097097 - Neonatal Resuscitation in Zambia Phase 3
Active, not recruiting NCT03133572 - Neonatal Resuscitation With Supraglottic Airway Trial N/A
Completed NCT01866358 - Intraosseous Infusion for Neonatal Asphyxiated Resuscitation N/A
Completed NCT00136708 - First Breath: Neonatal Resuscitation in Developing Countries N/A
Completed NCT04820504 - Augmented Infant Resuscitator to Enhance Newborn Ventilation N/A
Not yet recruiting NCT04145713 - Effects of Probiotic Mixture Supplementation and Evaluation of Intestinal Mucosal Tolerance and Gut Microbiome in Newborns With Perinatal Asphyxia Receiving Hypothermic Treatment Phase 3
Completed NCT03284528 - Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?" N/A
Completed NCT03278847 - Optimising Newborn Nutrition During Therapeutic Hypothermia.
Recruiting NCT04239508 - Swiss Neonatal Network & Follow-up Group
Recruiting NCT04714775 - Biomarkers And Neurological Outcome in Neonates 2
Active, not recruiting NCT05349175 - Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement N/A
Completed NCT03606278 - Evaluation of Two Strategies for Debriefing in the Development of Skills for Neonatal Resuscitation N/A
Completed NCT00147030 - TOBY: a Study of Treatment for Perinatal Asphyxia N/A
Withdrawn NCT03913533 - Heart Rate Assessment at Birth Comparing Stethoscope Versus Tap-based Application N/A
Recruiting NCT04867993 - Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia N/A
Active, not recruiting NCT03179553 - Heart Beat Variability in Neonatal Encephalopathy
Completed NCT03177980 - Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants